Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Nvidia building UK supercomputer to boost COVID-19 research

Published 05/10/2020, 14:05
Updated 05/10/2020, 14:10
© Reuters. FILE PHOTO: NVIDIA logo shown at SIGGRAPH 2017

© Reuters. FILE PHOTO: NVIDIA logo shown at SIGGRAPH 2017

LONDON (Reuters) - U.S. chip giant Nvidia (O:NVDA) said on Monday it is building Britain's most powerful supercomputer, which will use artificial intelligence to help researchers solve pressing medical challenges, including those related to COVID-19.

GSK (L:GSK) and AstraZeneca (L:AZN), which are both involved in coronavirus vaccine research, will be two of the first pharmaceutical companies to harness the power of the machine, Nvidia said.

The Cambridge-1 computer, which is expected to come online by the end of the year in Cambridge, east England, will be a NVIDIA DGX SuperPOD system capable of delivering more than 400 petaflops of AI performance, the company said.

That would mean it ranks 29th on the Top 500 list of the world's most powerful supercomputers, it said.

Cambridge is also home to Arm, the British chip designer that Nvidia has agreed to buy from Japan's SoftBank (T:9984) for $40 billion.

Nvidia has previously said it intended to create an AI Center of Excellence in the university city, featuring an Arm-based supercomputer, which will serve as a hub of collaboration for researchers, scientists and startups across the UK.

The separate Cambridge-1 supercomputer will be made available to researchers from industry and academia.

"The Cambridge-1 supercomputer will serve as a hub of innovation for the UK, and further the groundbreaking work being done by the nation's researchers in critical healthcare and drug discovery," said Jensen Huang, founder and CEO of Nvidia, in his GPU Technology Conference keynote speech.

© Reuters. FILE PHOTO: NVIDIA logo shown at SIGGRAPH 2017

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.